Dermatologic Manifestations in Patients with Systemic Disease




Abstract


Because of the frequency of skin involvement in systemic diseases, cutaneous manifestations often prove very helpful in establishing the correct diagnosis. The skin signs of systemic disease can be specific, e.g. cutaneous lupus, cutaneous sarcoidosis, in part because of associated histologic features, while others are best described as suggestive, e.g. pyoderma gangrenosum, acquired ichthyosis. Cutaneous findings that raise the possibility of an underlying malignancy, referred to as paraneoplastic, can serve as an early warning sign, appearing prior to the diagnosis of the associated malignancy. In general, paraneoplastic skin diseases improve if the associated malignancy responds to appropriate therapy and their recurrence should prompt a thorough search for recurrence of the cancer. In this chapter, the characteristic dermatologic manifestations of rheumatologic, hematologic/oncologic, gastrointestinal and cardiopulmonary disorders are reviewed, with cross references to more detailed descriptions in chapters throughout the book.




Keywords

cutaneous manifestations of systemic diseases, rheumatologic disease, endocrine disease, metabolic syndrome, hematologic disease, paraneoplastic skin diseases, paraneoplastic dermatoses, skin signs of systemic disease, acanthosis nigricans, gastroenterology and skin disorders, peristomal skin disorders, necrolytic migratory erythema, rheumatoid arthritis

 




Keywords

cutaneous manifestations of systemic diseases, rheumatologic disease, endocrine disease, metabolic syndrome, hematologic disease, paraneoplastic skin diseases, paraneoplastic dermatoses, skin signs of systemic disease, acanthosis nigricans, gastroenterology and skin disorders, peristomal skin disorders, necrolytic migratory erythema, rheumatoid arthritis

 





Key features





  • Because of the frequency of skin involvement in systemic diseases, cutaneous manifestations often prove helpful in establishing the correct diagnosis



  • Skin signs of systemic disease can be specific, e.g. cutaneous lupus, cutaneous sarcoidosis, in part because of associated histologic features, while others are best described as suggestive, e.g. pyoderma gangrenosum, acquired ichthyosis



  • Cutaneous disease can serve as the initial manifestation of a systemic disorder, including an internal malignancy



Skin disease is often associated with internal manifestations , e.g. psoriatic arthritis, and there are many cutaneous disorders that are traditionally associated with systemic disease. For example, rheumatologic disorders frequently have skin manifestations, as do infectious diseases and endocrinopathies. When one examines many of the disorders that are discussed elsewhere in this text, it becomes clear that isolated dermatologic disease is relatively uncommon. A detailed review of all dermatologic signs of internal disease is beyond the scope of this chapter. Rather, representative disorders are discussed individually, while the remainder are reviewed via tables that contain information relevant to dermatologists. Disorders are grouped on the basis of affected organ systems.




Cutaneous Rheumatology


The spectrum of disorders traditionally considered to be cutaneous rheumatology includes: lupus erythematosus ( Ch. 41 ); dermatomyositis ( Ch. 42 ); systemic sclerosis ( Ch. 43 ); vasculitides ( Ch. 24 ); and miscellaneous disorders. Miscellaneous disorders usually include: rheumatoid arthritis ( Ch. 45 ), reactive arthritis (formerly Reiter disease) ( Ch. 8 ), psoriatic arthritis ( Ch. 8 ), Behçet disease ( Ch. 26 ), pyoderma gangrenosum ( Ch. 26 ), Sweet syndrome ( Ch. 26 ), bowel-associated dermatosis–arthritis syndrome ( Ch. 26 ), Kawasaki disease ( Ch. 81 ), relapsing polychondritis ( Ch. 45 ), and several of the autoinflammatory disorders (see Table 45.7 ).


Cutaneous conditions reported in patients with rheumatoid arthritis are summarized in Table 53.1 ( Figs 53.1–53.5 ) . Dermatologists should be particularly careful in this group of patients to couple laboratory evaluation with a comprehensive cutaneous examination, including all mucosal surfaces, nails, nail folds, and hair. Clinical criteria are published for the diagnosis of many of these disorders; dermatologists should be familiar with these criteria and incorporate them into a focused, thorough history, which includes relevant negatives. It is very helpful to consider the clinicopathologic basis and pathogenesis of cutaneous lesions. For example, patients with systemic lupus erythematosus can have different types of photodistributed lesions with an interface histopathology, e.g. discoid, subacute, poikilodermatous, and they have different implications with regard to systemic disease. Such lesions are also treated differently than those caused by vessel-based pathology, e.g. small or larger vessel vasculitis.



Table 53.1

Cutaneous manifestations of rheumatoid arthritis (RA).

DDx, differential diagnosis; EBV, Epstein–Barr virus; LE, lupus erythematosus; TNF, tumor necrosis factor.
























































CUTANEOUS MANIFESTATIONS OF RHEUMATOID ARTHRITIS
Condition Features
Palisading granulomas
Rheumatoid nodules


  • Seen in ~20% of RA patients, often associated with high-titer rheumatoid factor (RF)



  • Firm, semi-mobile papulonodules favoring periarticular locations (e.g. elbows; see Figs 24.6B & 45.5) and other sites of repetitive trauma or pressure (e.g. the sacral region if bedridden)



  • Histologically, central zone of eosinophilic fibrin surrounded by palisaded histiocytes



  • DDx: subcutaneous granuloma annulare, gouty tophi, synovial hyperplasia/cysts (softer, painful)

Interstitial granulomatous dermatitis (IGD) and palisaded neutrophilic & granulomatous dermatitis (PNGD)


  • The clinical spectrum includes rheumatoid papules ( Fig. 53.1 ), the annular variant of IGD ( Fig. 53.2 ), and superficial ulcerating rheumatoid necrobiosis ( Fig. 53.3 )



  • See Ch. 93 for details

Neutrophilic dermatoses
Rheumatoid neutrophilic dermatitis (rheumatoid neutrophilic dermatosis)


  • Erythematous papules and plaques that may be vesiculated or crusted; favors extensor extremities



  • Unlike Sweet syndrome, not tender or associated with fevers and malaise

Sweet syndrome and pyoderma gangrenosum (PG) *
Neutrophilic lobular panniculitis


  • Tender red nodules favoring the lower legs; may ulcerate with purulent drainage

Vasculitis and vascular reactions
Bywaters lesions


  • Punctate purpuric papules on the distal digits due to cutaneous small vessel vasculitis ( Fig. 53.4 )

Rheumatoid vasculitis


  • Associated with long-standing (often “burnt out”) joint disease, high-titer RF, and mononeuritis multiplex; may also affect the eyes and internal organs



  • Cutaneous involvement is usually the first manifestation




    • Small vessel vasculitis : purpuric macules and papules (see Fig. 24.6B )



    • Medium-sized vessel vasculitis : nodules, ulcers, digital gangrene, livedo reticularis, atrophie blanche-like scars




  • Systemic disease requires aggressive immunosuppressive therapy

Intravascular/intralymphatic histiocytosis


  • Erythema, induration and papules in a reticular pattern overlying swollen joints, most often the elbows

Erythema elevatum diutinum


  • Firm, red to yellow-brown papulonodules and plaques, usually symmetrically distributed over joints and on extensor surfaces



  • Chronic cutaneous vasculitis, occasionally associated with RA

Complications of therapy for RA
NSAIDs


  • Pseudoporphyria ( Fig. 53.5 ), toxic epidermal necrolysis

Methotrexate


  • EBV-associated lymphoproliferative disease may involve the skin

Methotrexate ≫ TNF inhibitors


  • Accelerated rheumatoid nodulosis – sudden appearance of multiple papulonodules, especially on the hands (see Fig. 45.6 )

TNF inhibitors


  • Local injection site reactions, urticaria, urticarial eruptions, vasculitis, IGD, cutaneous LE, psoriasiform eruptions, palmoplantar pustulosis, dermatomyositis


* “PG-like” leg ulcers are a feature of Felty syndrome, which is characterized by the triad of neutropenia, splenomegaly, and RA; Felty syndrome may be associated with T-cell large granular lymphocyte leukemia.




Fig. 53.1


Rheumatoid papules.

Multiple red–brown papules, some with scale-crust, on the lower extremity. This entity is within the spectrum of palisaded neutrophilic and granulomatous dermatitis (see Table 53.1 ).



Fig. 53.2


Annular variant of interstitial granulomatous dermatitis (IGD).

This clinical presentation with annular plaques on the medial thighs is often seen in the setting of rheumatoid arthritis. Of note, IGD has also been implicated as a side effect of medications, including calcium channel blockers, TNF-α inhibitors, and HMG-CoA reductase inhibitors (“statins”).



Fig. 53.3


Superficial ulcerating rheumatoid necrobiosis.

Shiny, yellow plaques with red–brown edges and areas of ulceration that clinically resemble necrobiosis lipoidica. This patient had active rheumatoid vasculitis.



Fig. 53.4


Bywaters lesions.

Tender, purpuric papules on the distal fingers in a patient with rheumatoid vasculitis. Histologically, leukocytoclastic vasculitis is seen.



Fig. 53.5


Pseudoporphyria in a patient with rheumatoid arthritis.

The cause was a nonsteroidal anti-inflammatory drug.

Courtesy, Kalman Watsky, MD.


Sjögren syndrome is an autoimmune disorder that is characterized by keratoconjunctivitis sicca and xerostomia (see Table 45.4 ). In primary Sjögren syndrome, vascular inflammation within the skin (e.g. small vessel vasculitis, hypergammaglobulinemic purpura) can occur even before the clinical diagnosis of Sjögren syndrome has been established. Some patients from the Far East, including Japan and the Philippines, have been described with “annular erythema of Sjögren syndrome”. There is ongoing debate as to whether this disorder is unique to Sjögren syndrome or if it is, in fact, a form of subacute cutaneous lupus erythematosus . Secondary Sjögren syndrome occurs in patients with other rheumatologic diseases, including rheumatoid arthritis, dermatomyositis and systemic sclerosis. It is important to remember that the diagnosis of Sjögren syndrome is one of exclusion, and that other conditions can cause xerostomia/xerophthalmia, including chronic GVHD, sarcoidosis, primary systemic amyloidosis, hepatitis C viral infection, and HIV disease.




Cutaneous Hematology and Oncology


Disorders of mutual interest to the dermatologist and hematologist/oncologist are well covered in the following chapters of this textbook: metastatic disease ( Ch. 122 ), leukemia/lymphoma ( Chapter 119 , Chapter 120 , Chapter 121 ), dysproteinemias ( Ch. 119 ), histiocytoses ( Ch. 91 ), vascular neoplasms ( Ch. 114 ), cutaneous T-cell lymphoma ( Ch. 120 ), melanoma ( Ch. 113 ), and cutaneous reactions to chemotherapeutic agents ( Ch. 21 ). Skin signs of internal malignancy are summarized in Tables 53.2 and 53.3 .



Table 53.2

Paraneoplastic dermatoses .

AESOP syndrome – a denopathy, e xtensive s kin patch o verlying (a) p lasmacytoma. GI, gastrointestinal; GU, genitourinary; JMML, juvenile myelomonocytic leukemia; VEGF, vascular endothelial growth factor.
















































































































































PARANEOPLASTIC DERMATOSES
Dermatoses Cutaneous findings Comments
Disorders that are associated with cancer in most or all cases
Bazex syndrome (acrokeratosis paraneoplastica) Acral psoriasiform plaques, typically with involvement of the nose and helices; often the lesions are violaceous ( Fig. 53.6 ). Longitudinal and horizontal ridging of the nails occurs in 75% of patients By definition, this condition is linked to malignancy, occurring most commonly in the upper aerodigestive tract (pharynx, larynx or esophagus)
Carcinoid syndrome Flushing and erythema of the head and neck. Pellagra-like dermatitis and sclerodermoid changes may develop in advanced disease Flushing associated with ~10% of mid-gut tumors (small intestine, appendix, proximal colon) and liver metastases are required; type III gastric and bronchial carcinoid tumors are also associated with flushing (liver metastases are not required)
Erythema gyratum repens Concentric erythematous lesions, often giving rise to a wood-grain appearance ( Fig. 53.7 ; see Ch. 19 ) Variable sites and types of malignancy
Acquired hypertrichosis lanuginosa (malignant down) Growth of fine lanugo hairs in a generalized distribution or localized to the face. With time, these hairs may become coarser (see Ch. 70 ) Associated with a variety of internal malignancies, most often carcinoma of the lung, colon or breast
AESOP syndrome Large red to violet–brown patch Patch overlies a plasmacytoma
Ectopic adrenocorticotropic hormone (ACTH) syndrome Generalized hyperpigmentation that may be accentuated in sun-exposed sites Production of ACTH by a tumor (often a small cell carcinoma of the lung) may result in hyperpigmentation and features of Cushing syndrome
Glucagonoma syndrome Necrolytic migratory erythema, angular cheilitis, glossitis Due to a glucagon-secreting tumor of the pancreas. Patients are often treated for intertrigo before the syndrome is diagnosed. Weight loss and diabetes mellitus accompany the dermatosis
Paraneoplastic pemphigus Erosive disease of the mucous membranes and erythema multiforme-like, bullous pemphigoid-like or lichenoid skin lesions ( Fig. 53.8 ; see Ch. 29 ) Most often associated with non-Hodgkin lymphoma, chronic lymphocytic leukemia or Castleman disease (with the latter accounting for the majority of cases in children and Asian populations). Castleman tumors have been shown to produce the autoantibodies responsible for paraneoplastic pemphigus, and their resection can lead to remission of mucocutaneous lesions. Bronchiolitis obliterans is a common complication
Tripe palms Ridged velvety lesions on the palms May or may not be accompanied by acanthosis nigricans
Disorders that are strongly associated with cancer in a subset of cases
Acanthosis nigricans Rapid onset of hyperpigmented velvety changes in multiple flexural sites (e.g. neck, axillae, groin). May also involve extensor surfaces (e.g. elbows, knees, knuckles) and, in malignancy-associated cases, lips, oral mucosa, and palms (see above, tripe palms). Glossitis is also frequently present in patients with malignancy-associated acanthosis nigricans Association with adenocarcinoma of the stomach or other sites within the GI or GU tracts; in this setting, acanthosis nigricans is often accompanied by weight loss. Acanthosis nigricans is more commonly associated with endocrinologic abnormalities, in particular insulin resistance (see Fig. 53.14 ); such patients are typically overweight, and the onset of the condition is usually insidious
Anti-epiligrin cicatricial pemphigoid * /anti-laminin 332 mucous membrane pemphigoid Oral ulcerations, conjunctival erosions, and scarring. Tense blisters and erosions of the skin may also develop (see Ch. 30 ) Roughly one-third of patients have or develop cancer within the first year following diagnosis. The cancer is usually an adenocarcinoma and is often at an advanced stage at the time of diagnosis, possibly accounting for the high mortality rate
Dermatomyositis (adult) Heliotrope, Gottron papules, photodistributed poikiloderma, nail-fold overgrowth with dilated capillary loops, pruritus, and diffuse scaling of the scalp (see Ch. 42 ) Population-based studies demonstrate an over-representation of ovarian, lung, colorectal, and pancreatic carcinomas and non-Hodgkin lymphoma in Caucasians
Neutrophilic dermatoses Sweet syndrome ( Fig. 53.9 ) or pyoderma gangrenosum (particularly the atypical bullous form) (see Ch. 26 ) Approximately 10–20% of cases are associated with hematologic disorders such as acute myelogenous leukemia, myelodysplasia or plasma cell dyscrasia (IgA). Underlying solid tumors are rare
Disorders associated with a monoclonal gammopathy **
Acquired angioedema due to C1 esterase inhibitor dysfunction Acquired angioedema without associated wheals (see Ch. 18 ) Associated with B-cell lymphoproliferative disorders, including lymphomas, as well as monoclonal gammopathy of undetermined significance (MGUS)
Amyloidosis, primary systemic Waxy, translucent or purpuric papules; periorbital and pinch purpura; macroglossia (see Ch. 47 ) Monoclonal gammopathy due to plasma cell dyscrasia ≫ multiple myeloma; deposits composed of immunoglobulin light chain (AL)
Cryoglobulinemia, type I Retiform purpura and necrosis that favors cooler acral sites; acral cyanosis; livedo reticularis (see Ch. 23 ) Monoclonal gammopathy due to lymphoplasmacytic disorders
Necrobiotic xanthogranuloma Indurated xanthomatous plaques with necrosis and ulceration, usually in a periorbital location (see Ch. 91 ) Paraproteinemia (>80% of cases, most often IgG with κ light chains); multiple myeloma or a lymphoproliferative disorder develop in a minority of patients
Normolipemic plane xanthoma Yellowish patches and thin plaques that favor the skin folds, upper trunk and periorbital area (see Ch. 92 ) Paraproteinemia, due to a plasma cell dyscrasia or lymphoproliferative disorder
POEMS syndrome ( p olyneuropathy, o rganomegaly, e ndocrinopathy, M -protein and s kin changes) Although the glomeruloid hemangioma ( Fig. 53.10 ) is considered to be pathognomonic, it is present in a minority of patients. Other skin findings include cherry angiomas, hyperpigmentation, hypertrichosis, sclerodermoid induration, acrocyanosis, acquired facial lipoatrophy, hyperhidrosis, digital clubbing, plethora, and leukonychia Osteosclerotic myeloma, Castleman disease, and plasmacytomas have been reported in patients with POEMS. In addition to the findings designated in the acronym, patients may have peripheral edema, ascites, pulmonary effusions, papilledema, thrombocytosis, polycythemia, and increased serum levels of VEGF
Schnitzler syndrome Chronic urticarial lesions; histologically, a neutrophil-rich dermal infiltrate is often seen (see Ch. 18 ) Associated with an IgM, usually κ, paraproteinemia; lymphoplasmacytic malignancies develop in ~15% of patients. Additional manifestations include fevers, arthralgias and bone pain. Entity may be more common than previously reported , and treatment includes anti-IL-1 agents (see Fig. 45.13 )
Scleromyxedema Sclerodermoid induration plus firm, waxy papules arranged in linear arrays (see Ch. 46 ) Almost always associated with paraproteinemia (usually IgG with λ light chains); multiple myeloma develops in <10% of cases
Dermatoses that may be associated with cancer in a subset of patients
Acquired ichthyosis Resembles ichthyosis vulgaris; most often located on the legs Lymphoma typically predates the diagnosis of the ichthyosis
Cutaneous small vessel vasculitis Palpable purpura; may be widespread and/or in unusual locations (see Ch. 24 ) Less than 5% of patients with vasculitis have an associated malignancy, most commonly plasma cell dyscrasias, myelodysplasia, myeloproliferative or lymphoproliferative disorders, and hairy cell leukemia
Dermatitis herpetiformis (DH) Pruritic blisters and erosions on extensor surfaces, scalp and/or buttocks (see Ch. 31 ) Through the association of DH with gluten-sensitive enteropathy, enteropathy-associated T-cell lymphoma occasionally occurs
Eruptive disseminated porokeratosis Abrupt onset of numerous, widespread, inflamed keratoses. Histologically, features of porokeratosis In a literature review of 35 patients, ~30% of patients had an associated malignancy, most commonly involving the GI tract
Exfoliative erythroderma Widespread, diffuse, scaly erythematous skin (see Ch. 10 ) May be associated with cutaneous T-cell lymphoma or, occasionally, with a systemic lymphoma or leukemia
Juvenile xanthogranulomas (JXGs) in the setting of neurofibromatosis 1 (NF1) Pink–yellow to red–brown, dome-shaped papules and nodules, most often located on the head and neck (see Ch. 91 ) A triple association between JXGs, NF1 and JMML has been described
Multicentric reticulohistiocytosis Nodular lesions, most often on the dorsal aspects of the hands ( Fig. 53.11 ) A variety of associated malignancies reported, developing in approximately one-quarter of adult patients
Mycosis fungoides Patch, plaque or nodular disease (see Ch. 120 ) Some studies have demonstrated an increased risk of second malignancies, especially other lymphoid malignancies
Porphyria cutanea tarda (PCT) Erosions, blisters and scars on the dorsal aspect of the hands, hyperpigmentation, hypertrichosis, milia (see Ch. 49 ) Through its association with hepatitis C virus, PCT may also be associated with primary hepatocellular carcinoma (hepatoma)
Disorders whose association with cancer is controversial
Sign of Leser–Trélat Rapid appearance or growth of multiple seborrheic keratoses; keratoses may be inflamed There is ongoing controversy as to whether this represents a paraneoplastic phenomenon, as many adults have numerous seborrheic keratoses and it can be difficult to determine if the keratoses are truly eruptive. The rapid onset of numerous lesions, particularly if inflamed and associated with diffuse pruritus and/or acanthosis nigricans may warrant evaluation. Eruptive seborrheic keratoses can also develop in erythrodermic patients who do not have an underlying malignancy

* Evidence for this association is limited by the small number of affected individuals.


** For complete list, see Table 119.4 .




Fig. 53.6


Bazex syndrome (acrokeratosis paraneoplastica).

A Acral psoriasiform lesions that have a violaceous hue, accompanied by nail dystrophy. The patient had a squamous cell carcinoma (SCC) of the tonsillar pillar. B Thin hyperpigmented plaques of the helix and antihelix in a patient with SCC of the pharynx.

B, Courtesy, Jean L Bolognia, MD.



Fig. 53.7


Erythema gyratum repens.

This patient had cancer of the breast.



Fig. 53.8


Paraneoplastic pemphigus.

Lesions that resemble bullous pemphigoid in a patient with immunopathologic confirmation of paraneoplastic pemphigus despite an underlying malignancy not having been detected.



Fig. 53.9


Acute febrile neutrophilic dermatosis (Sweet syndrome).

Vesicopustules with surrounding erythema on the dorsal hand in a patient with myelodysplastic syndrome.



Fig. 53.10


POEMS syndrome.

This patient had multiple angiomas on his trunk as well as his face and scalp. All the angiomas that were examined histologically were glomeruloid hemangiomas. In addition, he reported a recent 10 lb (4.5 kg) weight loss, impotence and fatigue, and was found to have a neuropathy, adult-onset diabetes, hypothyroidism, and peripheral edema. His underlying disorder was an osteosclerotic myeloma.



Fig. 53.11


Multicentric reticulohistiocytosis.

Multiple nodules are present on the dorsal hands in this adolescent. This patient did not have a malignancy.


Table 53.3

Internal malignancies in familial cancer syndromes with cutaneous manifestations .

GI, gastrointestinal; GU, genitourinary; JMML, juvenile myelomonocytic leukemia.







INTERNAL MALIGNANCIES IN FAMILIAL CANCER SYNDROMES WITH CUTANEOUS MANIFESTATIONS



  • Cowden disease (breast, thyroid and GI carcinomas), Muir–Torre syndrome (GI and GU carcinomas), Gardner syndrome (GI carcinoma), Peutz–Jeghers syndrome (various malignancies) – see Table 53.10



  • Costello syndrome (rhabdomyosarcoma, bladder carcinoma), Werner syndrome (sarcomas and other malignancies) – see Table 53.12



  • Birt–Hogg–Dubé syndrome, hereditary leiomyomatosis and renal cell cancer – see Tables 111.1 & 117.2



  • Howel–Evans syndrome (esophageal carcinoma) – see Ch. 58



  • Ataxia–telangiectasia (leukemia, lymphoma, breast cancer) – see Ch. 60



  • Neurofibromatosis (malignant peripheral nerve sheath tumors, JMML, rhabdomyosarcoma, pheochromocytoma, carcinoid), tuberous sclerosis (renal carcinoma) – see Ch. 61



  • Multiple endocrine neoplasia syndromes – see Table 63.2



  • Dyskeratosis congenita (leukemia, Hodgkin disease) – see Ch. 67



  • Basal cell nevus syndrome (medulloblastoma, fibrosarcoma) – see Table 108.3



  • Bloom syndrome (lymphoproliferative and GI malignancies), Rothmund–Thomson syndrome (osteosarcoma), xeroderma pigmentosum (brain, especially sarcomas, and oral cavity [not just anterior tongue]) – see Table 87.4



  • Familial melanoma (pancreatic carcinoma, neural tumors, renal cell carcinoma, and gliomas, when mutations in CDKN2A (p16), CDKN2A (p14), MITF , and POT1 , respectively; uveal melanoma, mesothelioma, renal cell carcinoma, and cholangiocarcinoma with BAP1 mutations)



Both disease-specific and nonspecific skin lesions have been reported in association with myelodysplastic syndrome (MDS) . The former include leukemia cutis and “cutaneous myelodysplasia”; the latter is characterized by an infiltrate of atypical myeloid cells in a patient who does not fulfill the criteria for leukemia. The most commonly associated skin findings include neutrophilic dermatoses and vasculitis. A unique form of Sweet syndrome, which is preceded by a dense perivascular lymphocytic infiltrate, has been described in a few small cohorts of patients with MDS and may portend a poorer prognosis . Generalized granulomatous dermatitis, a variety of autoimmune disorders, including Behçet disease, relapsing polychondritis and bullous pemphigoid, and panniculitis have also been reported. In some patients, these cutaneous disorders precede the diagnosis of MDS, serving as its harbinger. Recurrence of skin lesions, or their lack of response to therapy, may herald progression to leukemia.


An eczematous or psoriasiform plaque of the nipple and surrounding skin can be seen in Paget disease due to epidermal extension of an underlying ductal adenocarcinoma of the breast ( Fig. 53.12 ). While extramammary Paget disease (EMPD) most commonly represents a primary intraepithelial adenocarcinoma (>75% of patients; Fig. 53.13 ), secondary EMPD can be due to an underlying visceral malignancy, e.g. colon, bladder (see Fig. 73.16 ).




Fig. 53.12


Paget disease of the breast.

A chronic, erythematous plaque surrounds the nipple.

Courtesy, Robert Hartman, MD.



Fig. 53.13


Extramammary Paget disease.

Eroded erythematous plaque with exudate, especially in the inguinal crease. The patient refused any further evaluation and had never undergone colonoscopy or cystoscopy.


Acanthosis nigricans is characterized by velvety hyperpigmentation of the intertriginous surfaces and, less often, extensor surfaces ( Figs 53.14 & 53.15 ). Although this disorder may be associated with an internal malignancy (most frequently gastric adenocarcinoma), it is most often associated with insulin resistance . The areas most frequently affected are the neck and axillae, but can include any skin fold, including that of the lower lip and chin. Malignancy-associated acanthosis nigricans is usually rapid in onset and may be accompanied by skin tags, multiple seborrheic keratosis, or tripe palms. Verrucous changes of the lips may also develop, and weight loss is common. In contrast, acanthosis nigricans associated with endocrine dysfunction is more insidious in onset and less widespread, and the patients are often overweight or obese. In either instance, there are probably one or more circulating factors that stimulate the epidermal proliferation (i.e. papillomatosis) that is observed histopathologically. An approach to the patient with acanthosis nigricans in outlined in Fig. 53.16 . Treatment of the underlying malignancy, or effective treatment of the endocrinopathy, including weight loss and use of insulin sensitizers, may result in improvement or disappearance of the acanthosis nigricans. Recurrence of malignancy-associated acanthosis nigricans requires a search for recurrent cancer.




Fig. 53.14


Acanthosis nigricans.

A Involvement of the posterior neck in a young woman with obesity and insulin resistance. There is also an acrochordon. B Axillary involvement in an obese 10-year-old Filipino boy with insulin resistance and a strong family history of type 2 diabetes mellitus.

B, Courtesy, Julie V Schaffer, MD.



Fig. 53.15


Acanthosis nigricans (AN) of the hands.

A Changes of AN overlie the knuckles in a patient with insulin resistance and obesity; acanthosis nigricans can involve extensor surfaces as well as flexural areas. B Diffuse involvement of the dorsal aspect of the fingers. Evaluation for an internal malignancy is recommended in patients with this type of clinical presentation.

A, Courtesy, Jean L Bolognia, MD; B, Courtesy, Joyce Rico, MD.



Fig. 53.16


Evaluation of the patient with acanthosis nigricans (AN).

FGFR, fibroblast growth factor receptor; HAIR-AN, hyperandrogenemia, insulin resistance, acanthosis nigricans; INSR, insulin receptor; SADDAN, severe achrondroplasia with developmental delay and AN.


The glucagonoma syndrome is characterized by the development of necrolytic migratory erythema (NME), adult-onset diabetes mellitus, weight loss, and glossitis. These patients are also frequently anemic, and personality changes may occur. Skin lesions of NME are eroded, erythematous patches and plaques that characteristically involve the intertriginous areas, face (especially around the mouth), and distal extremities. Blisters may occur and lead to erythematous erosions. The eruption, which can be painful or pruritic, remits and recurs over the course of several weeks to months. It is frequently misdiagnosed as intertrigo or as seborrheic dermatitis. Histologically, pallor of the upper epidermis is highly suggestive of NME or a “nutritional” dermatosis (see Ch. 51 ). However, psoriasiform hyperplasia of the epidermis is often seen in NME and therefore clinicopathologic correlation is required.


Most, but not all, patients with NME have a glucagon-secreting tumor of the pancreas, and effective treatment of the tumor will result in a disappearance of the disease. Rarely, NME develops in the setting of severe liver disease. Similar skin lesions occur in patients with deficiencies of zinc, fatty acids or biotin (see Fig. 51.13 ) and replacement therapy leads to resolution of the cutaneous findings. The differential diagnosis of NME also includes necrolytic acral erythema (see below).


There is growing recognition of the role both inherited and acquired disorders of hypercoagulability or thrombophilia play in various skin disorders (see Chs 23 and 105 ). Some associations, such as those between protein C deficiency and neonatal purpura fulminans or prothrombin gene mutations and livedoid vasculopathy, are fairly well understood. However, there are other disorders in which cutaneous thromboses have been identified (e.g. calciphylaxis) where the precise role remains less well defined. Evaluation for hypercoagulability is warranted in patients with unexplained cutaneous thrombosis (see Table 105.9 ).




Cutaneous Endocrinology and Metabolic Disease


Cutaneous manifestations may provide important clues to the diagnosis of endocrine disorders, including diabetes mellitus . Patients with endocrine diseases are especially susceptible to a number of associated mucocutaneous disorders.


Diabetes mellitus is a very common medical condition that affects almost every organ system. Table 53.4 summarizes cutaneous manifestations of diabetes mellitus ( Figs 53.17–53.22 ). Further details are available in reviews on the subject .



Table 53.4

Selected dermatologic associations of diabetes mellitus (DM).

Additional cutaneous conditions associated with DM include hirsutism (e.g. related to polycystic ovary syndrome or HAIR-AN – h yperandrogenemia, i nsulin r esistance, a canthosis n igricans; see Ch. 70 ), necrolytic migratory erythema (in the setting of DM due to a glucagon-secreting pancreatic tumor; see Table 53.2 ), compensatory and gustatory hyperhidrosis, and infections such as mucocutaneous candidiasis, erythrasma (especially the disciform variant), cellulitis, and necrotizing fasciitis.

Adapted from Jorizzo JL, Callen JP. Dermatologic manifestations of internal disease. In: Arndt KA, Robinson JK, LeBoit PE, et al (eds). Cutaneous Medicine and Surgery, Philadelphia: WB Saunders, 1996:1863–89.






































































SELECTED DERMATOLOGIC ASSOCIATIONS OF DIABETES MELLITUS
Dermatosis Clinical description Comments
Acanthosis nigricans (AN) Velvety hyperpigmentation of the intertriginous/flexural areas ( Fig. 53.14 ) and, less often, extensor surfaces ( Fig. 53.15A ) Commonly associated with insulin resistance in both adults and children. Most patients are obese. More common in Hispanics and individuals of African descent. Recent evidence strongly links AN in children with insulin resistance and diabetes
Acral dry gangrene Necrosis of the toes > fingertips Ischemia due to vascular disease in larger vessels
Acral erythema Erysipelas-like erythema of the hands and/or feet May be due to small vessel occlusive disease with compensatory hyperemia
Carotenoderma Diffuse orange–yellow skin color Related to an increase in serum carotene level
Diabetic bullae (bullosis diabeticorum) Tense non-inflammatory bullae on the lower extremities ( Fig. 53.17 ) Uncertain pathogenesis; microvascular angiopathy possible contributor
Diabetic cheiroarthropathy Thickened skin and limited joint mobility of the hands and fingers, leading to flexion contractures (starting with the fifth digit and progressing radially) and an inability to approximate the palmar surfaces of the hands and fingers (prayer sign; Fig. 53.18 ) Postulated to result from increased glycosylation of collagen in the skin. Associated with retinopathy, nephropathy, and duration (but not control) of the DM
Diabetic dermopathy Brown atrophic macules and patches on the legs ( Fig. 53.19 ) Possibly precipitated by trauma
Disseminated granuloma annulare Erythematous annular lesions composed of papules There is controversy about the exact relationship of disseminated granuloma annulare and DM (see Ch. 93 )
Eruptive xanthomas Red–yellow papules that appear over a period of weeks to months ( Fig. 53.20 ) Associated with elevated serum triglycerides in patients with poorly controlled diabetes. Control of the DM results in resolution of the xanthomas (see Ch. 92 )
Hemochromatosis Bronzing of the skin due to an increase in melanin rather than iron Excess of iron stores associated with cirrhosis and cardiac dysfunction as well as DM. Due to mutations in HFE , most commonly C282Y. Also risk factor for porphyria cutanea tarda
Necrobiosis lipoidica Yellow atrophic patches, most often on the shins. A red–brown rim may indicate activity at the border ( Fig. 53.21 ). Ulceration can occur and is often slow to heal Develops in <1% of patients with DM; diabeticorum was dropped from its name because not always associated with DM (see Ch. 93 )
Neuropathic leg ulcers Non-painful ulcerations at sites of pressure, most commonly on the foot ( Fig. 53.22 ). When the ulcer is on the plantar surface, a characteristic keratotic rim is seen Associated with sensory neuropathy (see Ch. 105 )
Perforating disorders (e.g. acquired perforating dermatosis) Keratotic papules, primarily on the extremities Often occurs in African-American diabetic patients with chronic kidney disease on dialysis (see Ch. 96 )
Rubeosis Chronic, flushed appearance of the face, neck and upper extremities Improved by dietary diabetic control. Flares with vasodilator therapies
Scleredema (adultorum of Buschke) Induration of the upper back and nape due to glycosaminoglycan deposition; may have overlying erythema No relationship to control of the DM. Also referred to as type III scleredema (see Ch. 46 )



Fig. 53.17


Bullosis diabeticorum (diabetic bullae).

Non-inflammatory bullae on the lower extremity in a patient with diabetes mellitus.



Fig. 53.18


Diabetic cheiroarthropathy (diabetic stiff hand syndrome).

Because of limited joint mobility and thickening of the skin of the hand, the patient is unable to appose the palms (“prayer sign”).

Courtesy, Jean L Bolognia, MD.



Fig. 53.19


Diabetic dermopathy.

Note the brown macules and patches on the shins.

Courtesy, Jean L Bolognia, MD.



Fig. 53.20


Eruptive xanthomas are frequently associated with poorly controlled diabetes mellitus.

This patient was first discovered to have diabetes following the appearance of these yellow–red papules.



Fig. 53.21


Necrobiosis lipoidica.

This plaque on the shin has an inflammatory border and a yellow color with atrophy and telangiectasias centrally. Controversy exists about the exact risk of diabetes mellitus in such patients, but it is much more strongly associated with diabetes than is granuloma annulare.



Fig. 53.22


Neuropathic ulcers on the toes of a patient with diabetic sensory neuropathy.


The primary characteristics of metabolic syndrome , previously known as syndrome X, are central obesity, hypertension, dyslipidemia, and type 2 diabetes. Almost all patients have insulin resistance, and it is associated with a high risk of cardiovascular disease. Clinical criteria for the diagnosis of metabolic syndrome are outlined in Table 53.5 . Women with polycystic ovary syndrome have a greater frequency of metabolic syndrome and often present with acanthosis nigricans, acne vulgaris, and hirsutism . An association between psoriasis vulgaris and metabolic syndrome has also been identified. Patients with moderate to severe psoriasis are at increased risk of atherosclerotic cardiovascular disease, which is linked to their propensity for the metabolic syndrome. The components of the metabolic syndrome – hyperlipidemia, diabetes mellitus, hypertension and obesity – are all established cardiovascular risk factors .



Table 53.5

Criteria for the clinical diagnosis of metabolic syndrome.

Metabolic syndrome is identified by the presence of three of these five criteria. Drug treatment for dyslipidemia, hypertension or hyperglycemia also fulfills the corresponding criterion. Most patients with type 2 diabetes mellitus meet criteria for metabolic syndrome.

Adapted from Alberti KGMM, Eckel RH, Grundy SM, et al. Harmonizing the metabolic syndrome: a Joint Interim Statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation. 2009;120:1640–5.







CRITERIA FOR THE CLINICAL DIAGNOSIS OF METABOLIC SYNDROME



  • Elevated waist circumference (population- and country-specific definitions)



  • Elevated triglycerides (≥150 mg/dl)



  • Reduced HDL (<40 mg/dl in males; <50 mg/dl in females)



  • Elevated blood pressure (systolic ≥130 and/or diastolic ≥85 mm/Hg)



  • Elevated fasting blood glucose (≥100 mg/dl)



Thyroid disease is also associated with a significant number of dermatologic disorders. Several reviews have highlighted these dermatologic manifestations and associations , and they are summarized in Table 53.6 .



Table 53.6

Dermatologic manifestations of thyroid disease.

Serum thyroid-stimulating hormone (TSH) level is the most reliable test of thyroid function; it is usually markedly suppressed in patients with hyperthyroidism. Additional laboratory findings in hyperthyroid patients include elevated free T 3 and/or free T 4 levels. Patients with primary hypothyroidism have elevated TSH levels and decreased free T 4 levels. The detection of anti-thyroid peroxidase and/or anti-thyroglobulin antibodies suggests autoimmune thyroid disease (Hashimoto thyroiditis, Graves disease) while the presence of anti-TSH receptor antibodies points to Graves disease. Ascher syndrome consists of blepharochalasis, double lip, and goiter.
































DERMATOLOGIC MANIFESTATIONS OF THYROID DISEASE
Hyperthyroidism Hypothyroidism
Cutaneous changes Fine, velvety, smooth skin
Warm and moist due to increased sweating
Hyperpigmentation – localized or generalized
Pruritus
Dry, rough, coarse skin
Cold and pale
Boggy and edematous skin (myxedema)
Yellow discoloration as a result of carotenoderma
Easy bruising (capillary fragility)
Cutaneous diseases Pretibial myxedema * , thyroid acropachy (acral soft tissue swelling, periostitis, and clubbing of the digits)
Urticaria, dermographism
Increased incidence of vitiligo
Acquired ichthyosis and palmoplantar keratoderma
Eruptive and/or tuberous xanthomas
Increased incidence of vitiligo
Hair changes/diseases Fine, thin
Mild, diffuse alopecia
Increased incidence of alopecia areata
Dull, coarse, brittle
Slow growth (increase in telogen hair phase)
Alopecia of the lateral third of the eyebrows
Increased incidence of alopecia areata
Nail changes Onycholysis Thin, brittle, striated
Koilonychia Slow growth
Clubbing from thyroid acropachy Onycholysis (rare)

* Can persist when patient is treated and becomes euthyroid or can be associated with euthyroid Graves disease.



Adrenal disease classically manifests as excessive (Cushing syndrome) ( Figs 53.23 & 53.24 ) or insufficient (Addison disease) corticosteroid activity ( Fig. 53.25 ); this can include gluco- and mineralocorticoids. Excessive production of adrenal androgens may also occur (see Ch. 70 ). Features of these syndromes are outlined in Table 53.7 (see Ch. 125 ).




Fig. 53.23


“Buffalo hump” of Cushing syndrome due to fat redistribution.

The patient also has evidence of hirsutism.

Courtesy, Judit Stenn, MD.



Fig. 53.24


Cushing syndrome with multiple striae.

Courtesy, Judit Stenn, MD.



Fig. 53.25


Diffuse hyperpigmentation of Addison disease.

The hyperpigmentation (shown in contrast to the physician’s hand) is accentuated in sun-exposed skin and can also involve sites of trauma, skin creases, and mucosae.


Table 53.7

Dermatologic manifestations of adrenal disorders.

Both over- and underproduction of adrenal hormones lead to characteristic skin findings. The plasma adrenocorticotropic hormone (ACTH) level is elevated in Cushing disease (pituitary overproduction) and ectopic ACTH syndrome, whereas it is suppressed in patients with adrenal tumors. Plasma ACTH levels are also elevated in patients with primary adrenocortical insufficiency (Addison disease) and suppressed in secondary adrenocortical insufficiency due to exogenous corticosteroid administration. When adrenal insufficiency is suspected, including in patients receiving a prolonged course of corticosteroids, an ACTH stimulation test can provide useful information. MSH, melanocyte-stimulating hormone.












DERMATOLOGIC MANIFESTATIONS OF ADRENAL DISORDERS
Cushing disease * Addison disease
Altered subcutaneous fat distribution



  • Rounded “moon” facies



  • Dorsal cervical fat deposition “buffalo hump” ( Fig. 53.23 )



  • Pelvic girdle fat deposition



  • Reduced fat in the arms and legs


Skin atrophy



  • Multiple striae ( Fig. 53.24 )



  • Fragile skin



  • Prolonged wound healing



  • Purpura from minor trauma


Cutaneous infections



  • Pityriasis (tinea) versicolor



  • Dermatophytosis and onychomycosis



  • Candidiasis


Acne
Hirsutism
Hyperpigmentation (MSH-like effect of ACTH)



  • Diffuse with accentuation in sun-exposed skin ( Fig. 53.25 )



  • Prominent at sites of trauma



  • Axillae, perineum, nipples



  • Palmar creases



  • Mucous membranes



  • Hair



  • Nails (longitudinal melanonychia)



  • Melanocytic nevi and lentigines


Loss of androgen-stimulated (axillary, pubic) hair in postpubertal women
Fibrosis and calcification of cartilage, including ear (rare)
In patients with candidiasis endocrinopathy syndrome, vitiligo and chronic mucocutaneous candidiasis

* Screening tests include late-night salivary cortisol, urine free cortisol (24-hour), 1-mg overnight low-dose dexamethasone suppression test (DST), and longer low-dose DST (2 mg/d for 48 h).





Cutaneous Gastroenterology


With the exception of Table 26.13 , cutaneous aspects of gastroenterologic or hepatic disease are not specifically discussed elsewhere in this text . Table 53.8 is a list of selected cutaneous associations of Crohn disease and ulcerative colitis ( Figs 53.26–53.28 ). Patients with ostomies, particularly those with an ileostomy, may develop peristomal dermatoses, the most common of which are listed in Table 53.9 . Table 53.10 lists dermatologic conditions associated with gastrointestinal bleeding or hemorrhage ( Figs 53.29–53.32 ) .



Table 53.8

Skin findings in Crohn disease and ulcerative colitis.

See Ch. 93 for discussion of mucocutaneous manifestations of Crohn disease.







SKIN FINDINGS IN CROHN DISEASE AND ULCERATIVE COLITIS



  • Erythema nodosum – often reflective of active bowel disease



  • Urticaria



  • Cutaneous small vessel vasculitis



  • Cutaneous polyarteritis nodosa



  • “Pustular” vasculitis or bowel-associated dermatosis–arthritis syndrome-like lesions



  • Pyoderma gangrenosum – primarily the classic (typical) ulcerative form ( Fig. 53.26 ) or peristomal lesions ( Fig. 53.27 ); a vegetative pustular variant (pyoderma vegetans) occasionally occurs. These lesions may or may not reflect activity of the bowel disease



  • Other neutrophilic dermatoses, ranging from acneiform lesions to Sweet syndrome to panniculitis



  • Oral lesions (see Chs 26 & 72 )




    • Granulomatous infiltrates (with Crohn disease only)



    • Aphthosis



    • Angular cheilitis



    • Pyostomatitis vegetans (mucosal variant of pyoderma gangrenosum)




  • Contiguous (anogenital) and “metastatic” Crohn disease ( Fig. 53.28 )



  • Fistulae (perianal and abdominal)



  • Genital lymphedema



  • Perianal skin tags



  • Acquired acrodermatitis enteropathica-like lesions (patients with zinc deficiency and/or essential fatty acid deficiency)



  • Epidermolysis bullosa acquisita



  • Psoriasis




Fig. 53.26


Pyoderma gangrenosum in a patient with ulcerative colitis and relapsing polychondritis.

Central ulceration preceded by a violaceous bulla with an inflammatory border.

Courtesy, Frank Samarin, MD.



Fig. 53.27


Peristomal pyoderma gangrenosum in the setting of inflammatory bowel disease.

Patients with ostomies, particularly ileostomies, are at risk for peristomal dermatoses, including pyoderma gangrenosum.



Fig. 53.28


“Metastatic” Crohn disease.

Non-contiguous granulomatous inflammation of the skin is often manifested by deep inflammatory fissures in the inguinal folds. These have been described as “knife-like” fissures.


Table 53.9

Peristomal skin disorders.

Peristomal skin disorders are common and may limit use and efficacy of the stoma appliance. When the etiology is uncertain, evaluation can include KOH examination, microbial cultures, patch testing, and histologic examination.

Adapted from Lyon CC, Smith AJ, Griffiths CE, Back MH. The spectrum of skin disorders in abdominal stoma patients. Br J Dermatol. 2000;143:1248–60.



























PERISTOMAL SKIN DISORDERS
Skin disorder Comments
Irritant contact dermatitis Most common cause of peristomal dermatitis, especially in patients with an ileostomy. Primarily attributed to exposure to feces or urine
Pre-existing skin disease (e.g. psoriasis, seborrheic dermatitis, atopic dermatitis) Exclude primary contact dermatitis or infection or superimposed contact dermatitis
Cutaneous infection ( Candida spp., dermatophyte, herpes virus [primarily simplex], bacteria [especially Staphylococcus aureus ]) Colonization with bacteria and/or yeast is common. Recent treatment with antibiotics predisposes to candidiasis. May initially improve then worsen if treated inappropriately with topical corticosteroids
Allergic contact dermatitis Relatively uncommon. Potential allergens include: adhesive pastes, adhesive ring or wafer of stoma bag, ostomy bag, epoxy resin, rubber, lanolin, and fragrances. Patch test with both standardized allergens and patient’s own products
Pyoderma gangrenosum Infrequent cause of peristomal dermatitis; most common in patients with inflammatory bowel disease ( Fig. 53.27 )
Pseudo-verrucous papules and nodules Seen more commonly in association with urostomies; may be misdiagnosed as verrucae


Table 53.10

Cutaneous diseases associated with gastrointestinal bleeding or hemorrhage.

CNS, central nervous system; GI, gastrointestinal; GU, genitourinary; HHV, human herpesvirus; SMAD, s mall (body size) plus m others a gainst d ecapentaplegic [involved in TGF-β signaling]; TGF, transforming growth factor.

Adapted from refs .














































































































CUTANEOUS DISEASES ASSOCIATED WITH GASTROINTESTINAL BLEEDING OR HEMORRHAGE
Disorder Cutaneous findings Gastrointestinal features Other pertinent findings Treatment and comments
Genetic (especially those associated with vascular malformations and GI polyps)
Hereditary hemorrhagic telangiectasia (HHT) Macular and papular telangiectasias on facial and acral skin as well as the oral mucosa ( Fig. 53.29 ).
Telangiectasias actually represent arteriovenous malformations (AVMs)
Recurrent hemorrhage in the upper GI tract due to AVMs
Subset of patients have both juvenile GI polyposis and HHT, most commonly due to mutations in SMAD4 ; associated risk of early-onset colorectal cancer
Epistaxis is often the initial manifestation. AVMs of the lungs, liver and CNS Autosomal dominant; ~80% of patients have mutations in ENG or ACVRL1 , which encode endoglin and ALK1, TGF-β receptors. Treatment consists of surgical resection, embolization or laser therapy of AVM causing hemorrhage
Blue rubber bleb nevus syndrome Subcutaneous blue to purple venous malformations ( Fig. 53.30 ) GI vascular malformations Possible vascular malformations in other organs (e.g. CNS, lungs) Mosaic due to double (cis) somatic TEK mutations in lesional tissue
Pseudoxanthoma elasticum Yellow papules and plaques on neck and in intertriginous zones, redundant lax skin Upper or lower GI hemorrhage Angioid streaks in the eye, hypertension, premature atherosclerosis, uterine hemorrhage, vascular calcification Autosomal recessive disorder due to mutations in ABCC6 . Diet high in magnesium may be helpful
Ehlers–Danlos syndrome, vascular type (type IV) Translucent fragile skin with extensive bruising GI hemorrhage due to arterial rupture or intestinal perforation Minimal joint hyperextensibility (limited to digits), rupture of other arteries or the uterus, acrogeric facies Autosomal dominant, deficiency of type III collagen
Gardner syndrome Epidermoid cysts, pilomatricomas, lipomas, fibromas, and desmoid tumors Hemorrhage from adenomatous colonic polyps. Adenocarcinoma of the colon is universal if the colon is not removed Mandibular and maxillary osteomas and cysts, c ongenital h ypertrophy of the r etinal p igment e pithelium (CHRPE) Autosomal dominant due to mutations in APC . Colectomy must be appropriately timed
Peutz–Jeghers syndrome Melanotic macules on mucosal surfaces ( Fig. 53.31 ) and, less often, on acral or perioral skin Hamartomatous polyps throughout the GI tract. Intussusception or hemorrhage may occur Increased incidence of breast, ovarian sex cord tumors with annular tubules, pancreatic, GI, and other cancers (e.g. lung, endometrial, cervical) Autosomal dominant due to mutations in STK11 , which encodes a serine/threonine kinase. Remove symptomatic areas of the bowel
Cowden syndrome (PTEN hamartoma syndrome; multiple hamartoma syndrome) Multiple facial or periorificial papules (tricholemmomas), perioral lentigines, cobblestoning of the oral mucosal surface ( Fig. 53.32 ), acral keratotic papules, sclerotic fibromas, lipomas Hamartomatous polyps throughout the GI tract.
Bleeding is rare
Fibrocystic breast disease along with frequent cancers of the breast, often bilateral. Thyroid tumors including cancer Autosomal dominant due to mutations in the PTEN tumor suppressor gene, which encodes a phosphatase
Muir–Torre syndrome Benign and malignant sebaceous neoplasms and multiple keratoacanthomas Colorectal and gastric carcinoma > carcinoma of the small bowel Cancer also may occur in the hepatobiliary and GU tracts Autosomal dominant due to mutations in one of several mismatch repair genes, including MSH2 (~90%) , MLH1 and MSH6
Inflammatory/autoimmune
Cronkhite–Canada syndrome Circumscribed areas of lentiginous hypermelanosis, alopecia, generalized nail thinning Adenomatous GI polyps, diarrhea, abdominal pain Weight loss due to malabsorption Malignant degeneration is unusual
Vasculitis Palpable purpura, necrotizing livedo reticularis, nodules, or ulcers Ulcerations secondary to vasculitis of the blood vessels in the bowel. May be more common in IgA-associated vasculitis (Henoch–Schönlein purpura) Arthritis and nephritis are two additional features of Henoch–Schönlein purpura Corticosteroids and/or immunosuppressive agents may or may not be effective
Malignant atrophic papulosis (Degos disease) Early lesions – pale red papules with central necrosis
Late lesions – atrophic ivory scars
Small infarctions in the GI mucosa. Hemorrhage and intestinal perforation may result in death CNS involvement, pleuritis, pericarditis No standard effective therapy. Eculizumab and treprostinil may be beneficial in some patients
Ulcerative colitis Erythema nodosum, vasculitis, pyoderma gangrenosum
See Table 53.8
Uniform and continuous inflammation of the large bowel. Rectal involvement is present in majority (>95%) of patients. Toxic megacolon may develop Aphthous stomatitis is common. Malignant degeneration in the large intestine is frequent in patients with uncontrolled, longstanding disease Treatment options include sulfonamides, immunosuppressives, corticosteroids, and total colectomy
Crohn disease Erythema nodosum, vasculitis, pyoderma gangrenosum, perianal fistulae, and metastatic Crohn disease
See Table 53.8
Chronic inflammation, often granulomatous, of the bowel. Skip areas occur Aphthous stomatitis, arthritis, chronic blood loss Treatment options include sulfonamides, metronidazole, corticosteroids and other immunosuppressives, including TNF-α inhibitors
Nutritional
Scurvy Perifollicular purpura, corkscrew hairs Collagen degeneration in the vasculature due to vitamin C deficiency. GI blood loss results in anemia Gingivitis with friable gums and easy bleeding, conjunctival hemorrhage, difficulty walking Vitamin C replacement
Neoplastic
Kaposi sarcoma Violaceous macules, papules, and nodules of the skin and oral mucosa Similar tumors may occur in the GI tract; possible complications include ulceration, bleeding, perforation and ileus, which are more common in HIV-associated than in classic type Includes HIV-associated, African-endemic, and classic subtypes, with the latter favoring elderly men of Mediterranean heritage; caused by HHV-8 infection Chemotherapy or radiation therapy may be helpful



Fig. 53.29


Hereditary hemorrhagic telangiectasia.

Several small red macules and papules on the lips.

Courtesy, Irwin Braverman, MD.



Fig. 53.30


Blue rubber bleb nevus syndrome.

Several venous malformations are evident on this patient’s tongue.



Fig. 53.31


Peutz–Jeghers syndrome.

Multiple brown macules on the vermilion lips and a few on the lower cutaneous lip.



Fig. 53.32


Gingival cobblestoning in Cowden disease.

This patient also had trichilemmomas and a “Cowden nodule” or sclerotic fibroma on the neck.


Table 53.11 lists selected dermatologic aspects of liver disease . Necrolytic acral erythema is an interesting disease that has been described in association with hepatitis C viral infection. This entity is histologically similar to necrolytic migratory erythema (see above), but is clinically distinct in that it primarily involves acral sites. The lesions present as painful or pruritic, pink to violet–brown plaques with hyperkeratosis ( Fig. 53.33 ). Blisters and erosions are common, and disease activity tends to wax and wane. Most reported cases have been associated with hepatitis C viral infection, and there has been variable success following treatment with oral zinc supplementation and/or treatment of the underlying hepatitis C viral infection.



Table 53.11

Dermatologic aspects of liver disease.






























DERMATOLOGIC ASPECTS OF LIVER DISEASE
Liver disease Dermatologic manifestations/associations Other features, treatment, and comments
Cirrhosis


  • Spider angiomas and other telangiectasias



  • Palmar erythema



  • Dilated abdominal wall veins



  • Terry nails (white nail bed)



  • Muehrcke nails (transverse white bands)



  • Sparse axillary, pubic and pectoral hair



  • Pruritus



  • Jaundice




  • Gynecomastia



  • Parotid enlargement

Primary biliary cirrhosis (PBC)


  • Jaundice



  • Diffuse hyperpigmentation



  • Xanthomas – eruptive, planar and, occasionally, tuberous



  • Pruritus



  • May coexist with systemic sclerosis

Cholestyramine, rifampin, ursodiol and naloxone may help to relieve pruritus. Osteoporosis is a common complication. Treatment options for PBC include ursodiol, colchicine, methotrexate, and liver transplantation
Hemochromatosis (“bronze diabetes”)


  • Generalized hyperpigmentation

Due to mutations in HFE , most commonly C282Y. Phlebotomy to reduce iron stores remains primary treatment
Wilson disease (hepatolenticular degeneration)


  • Kayser–Fleischer ring – golden brown or greenish circle of pigment in Descemet membrane at the periphery of the cornea



  • Blue lunulae



  • Pretibial hyperpigmentation

Autosomal recessive; due to mutations in ATP7B which encodes a copper-transporting ATPase. Treatment with copper-chelating drugs (penicillamine, trientine) or metallothionein-inducer drugs (zinc acetate); liver transplantation for hepatic failure
Hepatitis B and C viruses


  • Cutaneous small vessel vasculitis (B,C)



  • Cryoglobulinemic vasculitis (C≫B)



  • Urticarial vasculitis (B,C)



  • Polyarteritis nodosa (classic – B, cutaneous – C)



  • Necrotizing livedo reticularis (C)



  • Urticaria (B,C)



  • Porphyria cutanea tarda (C>B)



  • Pruritus (B,C)



  • Lichen planus – particularly erosive oral disease (C)



  • Necrolytic acral erythema ( Fig. 53.33 ) (C)



  • Gianotti–Crosti syndrome (B>C)



  • Erythema multiforme (B,C)



  • Erythema nodosum (B>C)



  • Sarcoidosis (following therapy with interferon and/or ribavirin) (C>B)

Treatment of hepatitis viral infections vary based on disease stage, patient comorbidities, and hepatitis C virus genotypes. Options for hepatitis B include: entecavir, tenofovir, lamivudine, adefovir, telbivudine, and interferon. There are multiple treatment regimens for hepatitis C: direct-acting antivirals (DAAs), which include hepatitis C protease and polymerase inhibitors, as well as pegylated interferon + ribavirin



Fig. 53.33


Necrolytic acral erythema.

This is a manifestation of hepatitis C viral infection.




Other Systemic Diseases With Cutaneous Manifestations


Sarcoidosis is an example of a multisystem disease with a range of cutaneous manifestations (see Ch. 93 ) . Table 53.12 reviews the cardiac and dermatologic features of multisystem disorders ( Figs 53.34 & 53.35 ) . Skin changes associated with pulmonary and renal disorders are summarized in Tables 53.13 and 53.14 , respectively ( Figs 53.36–53.38 ) .



Table 53.12

Cardiocutaneous abnormalities in multisystem disorders.

AI-CTD, autoimmune connective tissue disease; CNS, central nervous system; ECG, electrocardiogram; GI, gastrointestinal; EFEMP2, epidermal growth factor (EGF)-containing fibulin-like extracellular matrix protein 2; IVIg, intravenous immunoglobulin; LAMB, lentigines, atrial myxoma, mucocutaneous myxoma, blue nevi; LE, lupus erythematosus; NAME, nevi, atrial myxoma, myxoma of the skin, ephelides; TGF, transforming growth factor.

Adapted from Jorizzo JL, Callen JP. Dermatologic manifestations of internal disease. In: Arndt KA, Robinson JK, LeBoit PE, et al (eds). Cutaneous Medicine and Surgery, Philadelphia: WB Saunders, 1996:1863–89.


































































































































































































































CARDIOCUTANEOUS ABNORMALITIES IN MULTISYSTEM DISORDERS
Disease Cutaneous features Cardiovascular findings Comments
Genetic
Cardio-facio-cutaneous syndrome Generalized ichthyosis-like scaling, keratosis pilaris, café-au-lait macules, sparse curly hair, sparse or absent eyebrows and eyelashes Pulmonic stenosis, atrial septal defects, hypertrophic cardiomyopathy Autosomal dominant “RASopathy” due to mutations in four genes that encode proteins in the RAS/MAPK (mitogen-activated protein kinase) pathway (see Fig. 55.5 ): BRAF > MAP2K1, MAP2K2 > KRAS. Patients have characteristic facies, short stature and developmental delay
Costello syndrome Lax skin on the hands and feet, deep palmoplantar creases, periorificial papillomas, acanthosis nigricans, curly hair Pulmonic stenosis, hypertrophic cardiomyopathy, arrhythmias Autosomal dominant “RASopathy” due to mutations in two genes that encode proteins in the RAS/MAPK pathway: HRAS > KRAS . Patients have mental and growth retardation and an increased risk of rhabdomyosarcoma and bladder carcinoma
Carvajal syndrome Striate epidermolytic palmoplantar keratoderma, woolly scalp hair Dilated left ventricular cardiomyopathy Autosomal recessive disorder due to desmoplakin mutations
Cutis laxa Lax redundant skin with reduced elasticity Aortic dilation and rupture, pulmonary artery stenosis, right-sided heart failure Autosomal dominant (AD) and recessive (AR) forms due to mutations in several genes including those that encode elastin, EFEMP2/fibulin-4, fibulin-5, and V-type H + ATPase subunit (see Table 95.5 ); systemic involvement is more common in the AR form
Ehlers–Danlos syndrome (EDS) Variable degree of skin hyperelasticity and fragility (e.g. “cigarette” paper scars, ecchymoses) Classic and hypermobility types (I–III): aortic root dilation, mitral and tricuspid valve regurgitation or prolapse Due to mutations in the genes encoding collagen V (classic type), tenascin X (subset of classic and hypermobility types), collagen III (vascular type), and collagen I (cardiac valvular type)
Vascular type: arterial aneurysms, dissection and rupture
Cardiac valvular type: valvular abnormalities
Fabry disease Angiokeratoma corporis diffusum, hypohidrosis Hypertrophic cardiomyopathy, valvular abnormalities, conduction defects, progressive atherosclerotic disease of the coronary and cerebral arteries α-Galactosidase A deficiency, X-linked recessive disorder. Cardiac and cerebrovascular disease and renal failure are the usual causes of death
Hemochromatosis Generalized bronze hyperpigmentation Congestive heart failure, supraventricular arrhythmias Diabetes, cirrhosis. Genetic testing is available for HFE gene mutations
Homocystinuria Livedo reticularis, malar rash, tissue-paper scars, diffuse pigmentary dilution Atherosclerosis, arterial and venous thrombosis Autosomal recessive disorder most commonly due to homozygous cystathionine β-synthase (CBS) deficiency. Rarely due to deficiency of methylenetetrahydrofolate reductase (MTHFR) or other enzymes listed in Table 97.1 . Patients also exhibit marfanoid characteristics and ectopia lentis. Hyperhomocysteinemia (due to homozygous MTHFR deficiency ≫ heterozygous CBS deficiency) also increases risk of arterial and venous thrombosis
LEOPARD syndrome/Noonan syndrome with multiple lentigines Multiple lentigines, café-au-lait and café-noir macules ECG abnormalities, pulmonary artery stenosis L – lentigines, E – ECG abnormality, O – ocular hypertelorism, P – pulmonary stenosis, A – abnormalities of the genitalia, R – retardation of growth, D – deafness.
Autosomal dominant “RASopathy” due to mutations in PTPN11 (see Fig. 55.5 )
Loeys–Dietz syndrome (types I and II) Translucent skin, easy bruising, atrophic scarring Aortic aneurysms, arterial tortuosity; significant risk of aortic dissection and rupture, even at an early age Autosomal dominant disorder due to mutations in the genes that encode TGF-β receptor 1 and 2. Overlapping clinical features with Marfan syndrome and vascular type EDS. Craniofacial anomalies are seen primarily in type I
Marfan syndrome Striae, decreased subcutaneous fat Dilation and dissection of the ascending aorta, mitral valve prolapse and regurgitation Autosomal dominant disorder due to mutations in the gene that encodes fibrillin-1. Characterized by tall stature with long limbs, arachnodactyly, dolichocephaly, myopia and ectopia lentis. In addition to β-blockers, angiotensin II receptor blockers (e.g. losartan), which antagonize TGF-β signaling, can prevent aortic root dilation
Multiple endocrine neoplasia (MEN) types 2A (Sipple syndrome) and 2B (multiple mucosal neuroma syndrome) MEN 2A – notalgia paresthetica, macular or lichen amyloidosis, often with childhood onset Hypertensive crises due to pheochromocytomas (often bilateral) Autosomal dominant conditions due to mutations in the RET proto-oncogene. Also manifest with medullary cell carcinoma of the thyroid (MEN 2A and 2B), parathyroid adenomas (MEN 2A), and a marfanoid habitus (MEN 2B)
MEN 2B – neuromas of the eyelids, lips, tongue and other mucosal sites
Carney complex (NAME and LAMB syndromes) Cutaneous myxomas, blue nevi, lentigines, café-au-lait and café-noir macules Atrial myxoma Endocrine neoplasia of the adrenal glands, pituitary gland, and/or testes. Autosomal dominant disorder due to mutations in PRKAR1A ; 2 nd genetic locus on chromosome 2
Naxos disease Diffuse non-epidermolytic palmoplantar keratoderma, woolly scalp hair Arrhythmogenic right ventricular cardiomyopathy Autosomal recessive condition due to mutations in the gene that encodes plakoglobin; same clinical findings rarely caused by desmocollin 2 mutations
Neurofibromatosis 1 Café-au-lait macules, neurofibromas, intertriginous freckling (lentigines) Hypertension, essential or due to pheochromocytoma or renal artery stenosis Due to mutations in NF1 , which encodes neurofibromin; the latter interacts with the RAS/MAPK pathway (see Fig. 55.5 )
Hutchinson-Gilford progeria syndrome Sclerodermoid changes, mottled hyperpigmentation, loss of subcutaneous fat, alopecia Premature atherosclerosis Autosomal dominant premature aging syndrome due to mutations in the gene encoding lamins A and C
Pseudoxanthoma elasticum Yellow papules and plaques on neck and in intertriginous areas, redundant lax skin Premature atherosclerotic vascular disease, aortic aneurysm, hypertension Upper or lower GI hemorrhage, angioid streaks in the eye, uterine hemorrhage. Autosomal recessive disorder due to mutations in ABCC6
Tuberous sclerosis complex (TSC) Facial angiofibromas, periungual and ungual fibromas, ash leaf macules, shagreen patch Cardiac rhabdomyomas, arrhythmias Renal angiomyolipomas, CNS tumors, mental retardation, seizures. Due to mutations in TSC1 or TSC2 , which encode hamartin and tuberin, respectively
Werner syndrome Premature graying, alopecia, sclerodermoid changes, loss of subcutaneous fat, ankle ulcerations Premature atherosclerosis Myocardial infarction is usually responsible for death by the fifth decade. Autosomal recessive disorder due to mutations in RECQL2 , which encodes a helicase. Other features include cataracts and malignancy
Inflammatory/autoimmune
Behçet disease Oral and genital aphthae, pathergy, pustular vasculitis, pyoderma gangrenosum-like lesions, erythema nodosum-like lesions Pericarditis, coronary arteritis, myocarditis, arrhythmias, valvular disease; vasculitis of the vasa vasorum, primarily of large blood vessels Ocular and CNS involvement. Inflammatory bowel disease should be excluded
Dermatomyositis Gottron papules, heliotrope rash, photodistributed poikiloderma Usually asymptomatic; arrhythmias, conduction defects; pericarditis and congestive heart failure are rare Cardiac involvement is a poor prognostic sign
DRESS/DIHS (drug hypersensitivity with eosinophilia and systemic symptoms/ drug-induced hypersensitivity syndrome) Widespread morbilliform or urticarial eruption or erythroderma; facial edema often present ECG changes may simulate acute myocardial infarction; acute myocardial dysfunction and hypotension which may initially appear during taper of corticosteroids Fever, hepatitis, and peripheral eosinophilia common (see Table 21.9 ). Treatment consists of discontinuation of offending drug and corticosteroids; can follow levels of N-terminal pro-brain natriuretic peptide (NT-proBNP). Long-term consequences include thyroid dysfunction and possible autoimmune disease
Kawasaki disease (mucocutaneous lymph node syndrome) Glossitis, cheilitis, acral erythema, edema and desquamation, polymorphous eruption, conjunctival injection Coronary arteritis, coronary artery aneurysms High fever, lymphadenopathy. Treatment with IVIg and aspirin significantly decreases risk of coronary artery disease
Neonatal lupus erythematosus (NLE) Transient, non-scarring annular lesions of LE (SCLE-like) that favor the periorbital region Congenital heart block (CHB) Presumed to be due to transplacental passage of autoantibodies, most commonly anti-SSA/Ro, but anti-RNP also detected. May have transient cytopenias and hepatitis. Mothers often have a known AI-CTD (~50%) and in those without a known AI-CTD, a significant percentage will develop one over time. For mothers with anti-SSA/Ro antibodies, there is <1% chance of having a baby with NLE, but once have baby with NLE, chance in subsequent pregnancies is 25%
Systemic lupus erythematosus Malar erythema, photosensitivity, lupus skin lesions. Patients with antiphospholipid antibodies may have necrotizing livedo reticularis, leg ulcers or widespread cutaneous necrosis ( Fig. 53.34 ) Pericarditis, verrucous endocarditis (Libman–Sacks), coronary artery disease Anti-cardiolipin antibody may play a role. Treatment of LE with corticosteroids may predispose to coronary artery disease
Multicentric reticulohistiocytosis Erythematous nodules of the hands and, less often, the extremities and the face ( Fig. 53.11 ) Pericarditis, congestive heart failure, coronary artery disease, cardiomegaly Deforming arthritis is frequent
Psoriasis Well-demarcated, pink-to-red plaques with silvery scale on the elbows, knees and scalp, around the umbilicus, and in the gluteal cleft Increased risk of cardiovascular disease, including cerebrovascular and peripheral artery disease. In patients with moderate to severe psoriasis, possible increased risk of death from atherosclerotic cardiovascular disease High incidence of metabolic syndrome in patients with moderate to severe psoriasis (see Table 53.5 )
Relapsing polychondritis Beefy, red ears (sparing the lobes); inflammation in other tissues with cartilage (e.g. the nose). Late findings include floppy ears and weakness in other areas where the cartilage was affected ( Fig. 53.35 ) Aortic insufficiency, dissecting aortic aneurysm Arthritis, tracheal collapse. Dapsone may be helpful. Corticosteroids and/or other immunosuppressive agents are also used
Rheumatic fever Erythema marginatum, subcutaneous nodules Pancarditis in the acute phase. Late manifestations include mitral and/or aortic valve dysfunction Rare in US. Follows pharyngitis due to group A β-hemolytic streptococcal infection. Polyarthritis, chorea, fever
Sarcoidosis Papules, nodules, plaques and/or lesions in scars ( Fig. 53.36 ) Conduction defects, congestive heart failure Pulmonary disease, lymphadenopathy, hepatic involvement, hypercalcemia. Cardiac involvement denotes a poor prognosis
Systemic sclerosis (scleroderma) Cutaneous sclerosis, Raynaud phenomenon Pulmonary artery hypertension, conduction defects, pericarditis, visceral Raynaud phenomenon Cardiac involvement denotes a poor prognosis. May also have interstitial lung disease
Vasculitis Palpable purpura, nodules, livedo reticularis, ulcerations Coronary artery vasculitis Arthritis, GI colic or bleeding. Cardiac involvement is uncommon
Neoplastic
Primary systemic amyloidosis (AL) Pinch purpura, waxy skin, translucent papules, macroglossia Restrictive cardiomyopathy, conduction disturbances Proteinuria, urinary light chains, association with plasma cell dyscrasia ≫ multiple myeloma
Carcinoid syndrome Flushing; pellagra-like dermatitis and sclerodermoid features may occur as late manifestations Endocardial plaques – tricuspid insufficiency, conduction defects Flushing associated with ~10% of mid-gut tumors (small intestine, appendix, proximal colon) and liver metastases are required; type III gastric and bronchial carcinoid tumors are also associated with flushing (liver metastases are not required)
Infectious
Endocarditis – bacterial or fungal Purpura, nail-fold infarction, Janeway lesions, Osler’s nodes Vegetations and dysfunction of the valves Fever. May simulate vasculitis or cryoglobulinemia
Metabolic/endocrine
Diabetes mellitus See Table 53.4 Coronary artery and peripheral artery disease Occurs with both type 1 and type 2; insulin resistance may contribute
Hyperlipidemia Xanthomas of multiple types Coronary artery disease See Ch. 92
Other
Exfoliative erythroderma Exfoliative dermatitis High-output cardiac failure The eruption may be due to dermatitis, psoriasis, cutaneous T-cell lymphoma, a drug eruption or other causes
PHACE(S) syndrome Segmental infantile hemangioma, most often of the face and neck Coarctation of the aorta, atrial and ventricular septal defects, anomalous cervical and cerebral arteries P – posterior fossa malformations, H – hemangioma, A – arterial anomalies, C – cardiac defects and coarctation of the aorta, E – eye anomalies, S – sternal defects and supraumbilical raphe

Only gold members can continue reading. Log In or Register to continue

Stay updated, free articles. Join our Telegram channel

Tags:
Sep 15, 2019 | Posted by in Dermatology | Comments Off on Dermatologic Manifestations in Patients with Systemic Disease

Full access? Get Clinical Tree

Get Clinical Tree app for offline access